Clinical Characterization and Risk Factors Associated with Cytokine Release Syndrome Induced By COVID-19 and Chimeric Antigen Receptor T-Cell Therapy

Mostrar otras versiones (1)

Background: An excessive immune response during coronavirus disease (COVID-19) can induce cytokine release syndrome (CRS), which is associated with life-threatening complications and disease progression. Methods: This study was aimed to investigate the differences and similarities between CRS induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Ruimin, Zhao, Houli, Wang, Yiyun, Chen, Yu, Cai, Hongliu, Hu, Yongxian, Wei, Guoqing, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
704.Immunotherapies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330227/
http://dx.doi.org/10.1182/blood-2020-139007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330227/
http://dx.doi.org/10.1182/blood-2020-139007

Ejemplares similares